[ad_1]
BOSTON (AP) — BOSTON (AP) — Verve Therapeutics Inc. (VERV) on Thursday reported a loss of $54 million in its…
BOSTON (AP) — BOSTON (AP) — Verve Therapeutics Inc. (VERV) on Thursday reported a loss of $54 million in its second quarter.
The Boston-based company said it had a loss of 87 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 91 cents per share.
The biotechnology firm posted revenue of $2.1 million in the period.
_____
This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VERV at
Copyright
© 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
[ad_2]
